-
1
Perioperative genitourinary infection associated with sodium-glucose co-transporter 2 inhibitor use
Published 2018-09-01Subjects: “…Sodium glucose co-transporter inhibitor…”
Get full text
Article -
2
Eligibility of outpatients with chronic heart failure for sodium–glucose co‐transporter‐2 inhibitors
Published 2021-08-01Subjects: Get full text
Article -
3
Update on the Efficacy and Safety of Sodium–Glucose Co-Transporter 2 Inhibitors in Patients with Chronic Diseases: A Systematic Review and Meta-Analysis
Published 2025-01-01Subjects: “…sodium–glucose co-transporter inhibitor…”
Get full text
Article -
4
The Validation and Determination of Empagliflozin Concentration in the Presence of Grapefruit Juice Using HPLC for Pharmacokinetic Applications
Published 2024-03-01Subjects: Get full text
Article -
5
Prescription of quadruple therapy in heart failure with reduced ejection fraction during hospitalization
Published 2024-10-01Subjects: Get full text
Article -
6
New possibilities of nephroprotection in patients with chronic heart failure in combination with chronic kidney disease and diabetes mellitus 2 or without it
Published 2022-10-01Subjects: “…type 2 sodium-glucose co-transporter inhibitor…”
Get full text
Article -
7
The association between SGLT2 inhibitors and new-onset arrhythmias: a nationwide population-based longitudinal cohort study
Published 2020-06-01Subjects: “…Sodium–glucose co-transporter inhibitors…”
Get full text
Article -
8
The clinical cases of ketoacidosis in patients with 2 type diabetes treated with inhibitors of sodium-glucose co-transporter
Published 2021-09-01Subjects: Get full text
Article -
9
Efficacy of Sodium‐Glucose Cotransporter‐2 Inhibitors in Patients With Acute Myocardial Infarction: A Meta‐Analysis of Randomised Controlled Trials
Published 2024-09-01Subjects: Get full text
Article -
10
The association between SGLT2 inhibitors and new-onset acute coronary syndrome in the elderly: a population-based longitudinal cohort study
Published 2023-08-01Subjects: “…Sodium–glucose co-transporter inhibitors…”
Get full text
Article -
11
Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem
Published 2021-06-01Subjects: Get full text
Article -
12
-
13
The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial
Published 2022Subjects: Get full text
Get full text
Get full text
Journal Article -
14
-
15
Ventricular remodeling and hemodynamic changes in heart failure patients with non-ischemic dilated cardiomyopathy following dapagliflozin initiation
Published 2024-06-01Subjects: “…Sodium–glucose co-transporter inhibitors (SGLT-2i)…”
Get full text
Article